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Abstract.  Differentiation of 3T3T cells into adipocytes 
results in the progressive repression of growth factor 
responsiveness. This is associated with the transcrip- 
tional repression of the inducibility of c-jun and ]unB 
expression by serum. In contrast, differentiation of SV- 
40 large T antigen-transformed 3T3T cells (CSV3-1) 
does not repress growth factor responsiveness nor c-jun 
or junB inducibility even though CSV3-1 cells can dif- 
ferentiate into adipocytes. To better explain these ob- 
servations, we have studied compositional changes in 
AP-1 DNA binding activity attributed to c-Jun, JunB, 
and JunD during the differentiation process in 3T3T 
and CSV3-1 cells. The results show that in nontrans- 
formed 3T3T cells, differentiation  represses AP-1 DNA 
binding activity via a proportionate downregulation of 
c-Jun, JunB, and JunD. In contrast, in CSV3-1 cells, 
AP-1 DNA binding activity increases twofold during 
differentiation,  which is accounted for by an increase in 
JunD with no change in c-Jun and JunB. If c-Jun and 
JunB serve as positive regulators and JunD serves as a 
negative regulator for cell proliferation as suggested by 
previous studies, the repression of JunD expression in 
differentiating CSV3-1 cells should be mitogenic be- 
cause decreasing JunD/AP-1 DNA binding activity 
would allow c-Jun/AP-1 and JunB/AP-1 DNA binding 
activities to be dominant. The results confirm this pre- 
diction showing that antisense junD oligodeoxyribonu- 
cleotides are mitogenic for differentiating CSV3-1 cells 
whereas antisense c-jun and junB inhibit mitogenesis. 
These data support the conclusion that differentiation 
can regulate cellular proliferative potential by modulat- 
ing the balance of positive and negative Jun/AP-1 DNA 
binding activities in distinct ways in nontransformed 
and transformed cells. 
T 
HE processes of proliferation and differentiation are 
integrally controlled in that differentiation can pro- 
gressively repress  cellular proliferative potential in 
nontransformed cells. One of the best studied in vitro ex- 
amples  of this involves murine 3T3T mesenchymal stem 
cells  that show a  predilection to undergo the multistep 
process  of adipocyte differentiation (Scott et al.,  1982b; 
Wang et al., 1994). The first step involves arrest of prolifer- 
ation at a distinct G1 cell cycle restriction point (Scott et al., 
1982a). At this predifferentiation growth arrest state, ceils 
possess the potentiality to undergo adipocyte differentia- 
tion if they are maintained in differentiation-inducing  me- 
dium or to reinitiate proliferation if they are exposed to 
appropriate growth factors.  The next step is designated 
nonterminal differentiation where cells express  an adipo- 
Address all correspondence to Dr. R.E. Scott, Department of Pathology, 
The University of Tennessee Medical Center, Memphis, TN 38163. Tel.: 
(901) 448-7020. Fax: (901) 448-6979. 
Dr. H. Wang's current address is Department of Pathology, The Uni- 
versity of Chicago, 5841 South Maryland Ave., Chicago, IL 60637. 
cyte morphology and also show a marked decrease in their 
growth  factor  responsiveness  (Hoerl  and  Scott,  1989). 
Nonterminally differentiated cells do however retain their 
proliferative potential and can be stimulated to reenter the 
cell cycle when treated with very high concentrations of 
FBS (Hoerl and Scott,  1989). Cells at the nonterminally 
differentiated state can also be induced to undergo termi- 
nal differentiation  wherein they irreversibly lose their pro- 
liferative potential and become unresponsive to all tested 
growth factors (Wier and Scott, 1986a). 
Many neoplastically transformed cells show defects in 
their proliferation and differentiation control mechanisms 
(Wille and Scott, 1986; Estervig et al., 1990). Transformed 
cells  typically  show  a  markedly reduced serum require- 
ment for growth, decreased requirement for substrate at- 
tachment,  and  aberrant  differentiation  characteristics. 
Some transformed cells may, however, nonterminally dif- 
ferentiate even  though they cannot  adequately repress 
proliferative potential to cause irreversible terminal differ- 
entiation. 
To enhance our understanding of the biology that un- 
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tiation in transformed cells, we have developed a  highly 
useful model cell system during the past several years. This 
system includes the cell line designated CSV3-1, which was 
derived from 3T3T cells via transformation by SV-40 large 
T antigen (Estervig et al., 1990). Unlike other SV-40 T an- 
tigen-transformed cells, CSV3-1  and several related cell 
lines retain the ability to differentiate into adipocytes and 
can undergo predifferentiation growth arrest and nonter- 
minal  differentiation  as  efficiently  as  nontransformed 
3T3T cells. However, the progressive reduction in growth 
factor responsiveness associated with differentiation does 
not occur in CSV3-1 ceils and the terminal step of differ- 
entiation that  is  associated  with  the  irreversible loss  of 
proliferative potential is blocked. For example, under the 
conditions  that  induce  terminal  differentiation in  3T3T 
cells, CSV3-1 adipocytes can reinitiate DNA synthesis and 
dedifferentiate after treatment with serum at concentra- 
tions of as low as 5% (Estervig et al.,  1990). In addition, 
CSV3-1  cells at the predifferentiation growth arrest and 
nonterminal differentiation states show an increased mito- 
genic responsiveness to certain atypical mitogens includ- 
ing vanadate and insulin, whereas 3T3T cells show no re- 
sponse to these agents (Wang and Scott, 1991; Wang et al., 
1991). 
The molecular mechanisms that mediate the progressive 
loss of cellular proliferative potential during adipocyte dif- 
ferentiation have not been fully explained, but numerous 
changes in gene expression are known to occur (Wier and 
Scott,  1986a,  1987;  Minoo  et  al.,  1989;  Sadowski  et  al., 
1992; Spiegelman et al., 1993; Vasseur-Cognet and Lane, 
1993).  In this regard, we recently demonstrated that two 
immediate early growth factor response protooncogenes, 
c-jun and junB, are critically important in mediating the 
control of proliferation in both nontransformed and trans- 
formed cells. When nontransformed 3T3T cells undergo 
nonterminal  adipocyte differentiation,  the  reduction  of 
growth factor responsiveness is associated with a selective 
repression in the inducibility of c-jun and junB by serum 
growth factors. The repression occurs at the transcription 
level and can be reversed by treatment with protein syn- 
thesis inhibitors or higher serum concentrations. This ef- 
fect is specific because the serum inducibility of other im- 
mediate early response genes, such as c-fos and c-myc, is 
not affected by differentiation (Wang and Scott, 1994). On 
the other hand, the increased mitogenic responsiveness of 
SV-40 T  antigen-transformed CSV3-1  cells to vanadate, 
which occurs during the differentiation process, is associ- 
ated with a selective induction of c-jun and junB without 
inducing c-los and c-myc (Wang et al., 1991). 
Both c-jun and junB are members of the jun protoonco- 
gene family that also includes junD. The products of these 
genes contain a leucine zipper domain and a basic region 
that mediate protein-protein interactions and DNA bind- 
ing (Angel and Karin, 1991). It is well established that all 
three Jun proteins possess indistinguishable abilities to form 
either  homodimers  among  themselves  or  heterodimers 
with Fos proteins including c-Fos, FosB, Fra-1, and Fra-2 
(Nakabeppu et al., 1988). Both Jun-Fos heterodimers and 
Jun-Jun  homodimers, known as AP-1  transcription fac- 
tors, bind to DNA at AP-1 sites and regulate the transcrip- 
tional activity of AP-1--dependent genes that are impor- 
tant  in  the  control  of  cell  growth  and  differentiation 
(Angel  and  Karin,  1991).  Compared  with  Jun-Jun  ho- 
modimers, Jun-Fos heterodimers bind DNA more tightly 
and are more potent regulators of transcription (Abel and 
Maniatis,  1989).  Fos proteins, on the other hand, cannot 
form  homodimers  and  thus  cannot  independently bind 
DNA (Angel and Karin, 1991). From this perspective, Jun 
proteins are more important than Fos proteins in regulat- 
ing gene expression because they are absolutely required 
for AP-1 functioning. 
To  investigate  further  the  molecular  mechanisms  by 
which adipocyte differentiation represses growth factor re- 
sponsiveness  in  nontransformed  cells  but  not  in  trans- 
formed cells, the AP-1 DNA binding activity mediated by 
c-Jun,  JunB,  and  JunD  and  the  levels of expression of 
these Jun proteins at the different biological states during 
the  process of adipocyte differentiation were  examined. 
The effects on cell proliferation of inhibiting the expres- 
sion  of individual  Jun  proteins using  antisense  oligode- 
oxyribonucleotides were also investigated. The results in- 
dicate  that  cellular  proliferative potential  is  differently 
regulated by differentiation in nontransformed and trans- 
formed cells through a changing balance between positive 
and negative Jun/AP-1 DNA binding activities. 
Materials and Methods 
Cell Lines and Culture 
Murine 3T3T mesenchymal  stem cells and CSV3-1 cells were used in these 
experiments. 3T3T cells (Diamond et al., 1977)  are nontransformed and 
can undergo all the defined steps in the adipocyte differentiation process 
(Scott et al., 1982b).  CSV3-1 ceils are SV-40 large T antigen-transformed 
3T3T cells that can undergo predifferentiation growth arrest and nonter- 
minal adipocyte differentiation but not terminal differentiation (Estervig 
et al., 1989,  1990).  Growing cells were routinely cultured at 37~C in 5% 
CO2/95% air in DME (Sigma Chemical Co., St. Louis, MO) supplemented 
with 10% FBS (HyClone, Logan, UT). 
Induction of Predifferentiation  Growth Arrest and 
Adipocyte Differentiation 
To induce predifferentiation growth arrest at the G 1 phase cell cycle re- 
striction point that is a prerequisite for adipocyte differentiation (Scott et al., 
1982a, b), 3T3T or CSV3-1 cells were directly passaged onto tissue culture 
plates or onto ethylene oxide-sterilized bacteriological petri dishes at 2.5 × 
103 cells/cm  2 in heparinized DME containing 25% human plasma and 10  -5 
M  biotin, a medium that induces adipocyte differentiation (Wang et al, 
1994).  Most cells arrested their growth within 4 d in this differentiation- 
promoting medium before expressing the adipocyte phenotype. Growth 
arrest was documented by demonstration of a marked decrease in DNA 
synthesis as determined by [methyt-3H]thymidine incorporation  (Wang 
and Scott, 1991). 
To induce nonterminal adipocyte differentiation, ceils were passaged 
onto 100-mm ethylene oxide-sterilized bacteriological petri dishes at 5 x 
103 cells/cm  2 in heparinized DME containing 25% CEPH. As described 
previously, CEPH is a defined fraction of human plasma that is deficient 
in aproliferin, the protein that induces the terminal loss of cellular prolif- 
erative potential during differentiation (Wier and Scott, 1986b; Wang et al., 
1994). Adipocyte differentiation of 3T3T cells induced by CEPH has been 
shown to be nonterminal because such adipocytes retain the ability to un- 
dergo DNA synthesis  when stimulated with 30% FBS (Scott et al., 1982b). 
In this medium, both 3T3T and CSV3-1 cells express an adipocyte pheno- 
type at d 6-8. 
Preparation of Nuclear Protein Extraction 
Nuclear extracts were prepared as previously described (Ye and Samuels, 
1987).  Briefly, cell monolayers were rinsed twice with 4°C PBS (pH 7.4) 
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500 g for 5 rain at 4°C, cell pellets were resuspended in 4 ml of 4°C STM 
buffer that contains 20 mM Tris-HCl (pH 7.85), 250 mM sucrose, 1.1 mM 
MgC12, and 0.2% Triton X-100 and incubated on ice for 5 min. The cell 
pellets were then washed once with STM buffer containing 0.2% Triton 
X-100 and once with STM buffer not containing Triton X-100. The iso- 
lated nuclei were then resuspended in STM buffer (without Triton X-100) 
that contains 0.4 M KC1 and 5 mM 13-mercaptoethanol and incubated on 
ice for 10 rain to extract nuclear proteins. After centrifugation at 2,000 g 
for 10 min at 4°C, the supernatant was collected, aliquoted, and frozen at 
-80°C before use. When needed, the protein concentrations were deter- 
mined by using a  protein assay kit  (Bio Rad Laboratories, Richmond, 
VA) according to the supplier's instructions. 
Electrophoretic Mobility Shift Assay and Gel 
Supershift Assay 
The double-stranded oligonucleotides used in these experiments included 
5'-CGCTTGATGACTCAGCCGGAA-3'  which  contains  a  consensus 
AP-1  binding site  that is underlined  (Santa  Cruz Biotechnology, Inc., 
Santa Cruz, CA). These oligonucleotides were radioactively end labeled 
with  [y-32p]ATP (3,000 Ci/mmol; Amersham Corp., Arlington Heights, 
IL)  and T4 polynucleotide kinase (Promega Corp.,  Madison, WI).  For 
mobility shift assays, 0.035  pmol 32p-labeled  oligonucleotides (N30,000 
cpm) and 10 p,g nuclear protein (in 2 p.l) was incubated in a total vol. of 25 p~l 
in the presence of 2 mM Tris-HCl (pH 7.5), 8 mM NaCI, 0.2 mM EDTA, 
0.2 mM 13-mercaptoethanol, 0.8%  glycerol, and 1  }xg poly(dI-dC).  The 
binding reactions were allowed to proceed at room temperature for 20 
min. Thereafter, 2 p.1 of bromophenol blue (0.1% in water) was added and 
protein-DNA complexes were resolved by electrophoresis on nondena- 
turing 5% polyacrylamide gels and visualized by autoradiography. 
For gel supershift assays, 1 p,g (in 1 i~1) of TransCrnz  TM supershift anti- 
body was added to the reaction mixture and incubated for additional 30 
min at room temperature. The antibodies used in these experiments in- 
cluded rabbit polyclonal IgG raised against either c-Jun, JunB, or JunD, 
and a polyclonal antibody raised against all Fos proteins including c-Fos, 
FosB, Fra-1, and Fra-2. All these gel supershift antibodies were purchased 
from Santa Cruz Biotechnology, Inc. 
Western Immunoblotting Analysis 
10 p,g of nuclear protein used for gel mobility shift assays were mixed with 
SDS sample buffer, boiled for 5 min, and then subjected to electrophoresis 
on 10%  SDS--polyacrylamide gels. Western immunoblotting procedures 
were performed as described (Otter et al., 1987).  After the transfer of the 
proteins onto nitrocellulose filters, immunological evaluation on c-Jun, 
JunB, and JunD expression was performed by using ECL Western blot- 
ting analysis kit (Amersham Corp.) using polyclonal antibodies that had 
been used for gel supershift assays as described above. 
Oligodeoxyribonucleotide Design, Cell Treatment, and 
[3H]Thymidine Incorporation Assay 
Phosphothionate-modified antisense and sense oligodeoxyribonucleotides 
corresponding to codons 1-6 of routine c-jun,  junB, and junD were synthe- 
sized on a DNA synthesizer (Applied Biosystems, Inc., Foster City, CA) 
at St. Jude Children's Research Hospital and purified by ethanol precipi- 
tation and multiple washes in 70% ethanol. They were lyophilized to dry- 
ness and redissolved in DME at a concentration of 2 ~g/p~l.  The sequences of 
these antisense and sense oligodeoxyribonucleotides are: c-jun antisense: 
5'-TI'CCATCI'TFGCAGTCAT-3'; c-jun sense: 5'-ATGACTGCAAA- 
GATGGAA-3'; junB antisense: 5'-TTCCATI'I'ICGTGCACAT-3'; ]unB 
sense:  5'-ATGTGCACGAAAATGGAA-3'; junD  antisense:  5'-ATA- 
GAAGGGCGTYI'CCAT-Y; junD  sense: 5'-ATGGAAACGCCCTTC- 
TAT-3', 
For these assays, cells were cultured in 12-well tissue culture plates for 
4  d  in DME containing 25% human plasma and 10  -5 M biotin to induce 
predifferentiation growth arrest. Thereafter, two  approaches were  em- 
ployed to determine if antisense oligodeoxyribonucleotides could affect 
cell growth: (1) Cells were cultured with either antisense or sense oligode- 
oxyribonucleotides in differentiation-promoting medium at the concen- 
trations between 0 and 80 Ixg/ml for 24 to 30 h in the presence of 2.5 ixCi/ 
ml of [methyl-3H]thymidine (7(~85 Ci/mmol; Amersham Corp.). The abil- 
ity of cells to synthesize DNA was measured by [3H]thymidine incorpora- 
tion as determined by scintillation counting. (2) Cells at the predifferentia- 
tion growth arrest state were rinsed twice with DME and refed with DME 
buffered  with  15  mM  N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic 
acid. Antisense or sense oligodeoxyribonucleotides were added at appro- 
priate concentrations. After 2 h incubation, FBS was added to reach a fi- 
nal concentration of 10%. Cells were further incubated for 24 to 30 h in 
the presence of 2.5 p.Ci/ml of [methyl-3H]thymidine. Thymidine incorpo- 
ration into DNA was then determined as above. For both approaches, the 
effects of various oligodeoxyribonucleotides on the expression of each Jun 
protein were analyzed by Western blotting as described above. 
Results 
Correlation of AP-1 DNA Binding Activity with 
Proliferative Potential during Differentiation 
Previous studies have shown that during the adipocyte dif- 
ferentiation process, nontransformed 3T3T cells progres- 
sively lose  their  growth  factor  responsiveness,  whereas 
transformed CSV3-1  cells retain their proliferative poten- 
tial. CSV3-1  cells even show an increased mitogenic re- 
sponsiveness to several unconventional mitogens, such as 
insulin and vanadate (Hoed and Scott, 1989; Estervig et al., 
1990; Wang et al., 1991; Wang and Scott, 1991, 1994, 1995). 
These differences in mitogenic responsiveness are summa- 
rized in Table I. 
Since the reduction in growth factor responsiveness dur- 
ing differentiation in 3T3T cells is associated with a selec- 
tive repression in c-jun and junB inducibility and since the 
increased mitogenic responsiveness to vanadate in CSV3-1 
cells is associated with a selective induction of c-jun and 
junB  (Wang et al.,  1991; Wang and Scott, 1994),  experi- 
ments were designed to investigate changes in AP-1 DNA 
binding  activity during  differentiation. Nuclear  extracts 
were prepared from 3T3T  and CSV3-1  cells at growing, 
predifferentiation growth arrest, and nonterminal differ- 
entiation states and electrophoretic mobility shift assays 
were  performed using 3Zp-labeled  oligonucleotides con- 
taining a single AP-1 binding site. Fig. 1 shows that at the 
growing state, no significant difference in AP-1 binding ac- 
tivity between 3T3T and CSV3-1  cells is evident, which is 
consistent with previous observations that SV-40  large T 
antigen does  not  activate  AP-1  (Wasylyk et  al.,  1988). 
However, when 3T3T and CSV3-1 cells were compared at 
the various stages of the differentiation process, marked 
differences were observed. As 3T3T cells underwent adi- 
pocyte differentiation, the AP-1 DNA binding activity de- 
creased dramatically. At the predifferentiation growth ar- 
rest state AP-1 DNA binding activity decreased by ~80% 
and  at  the  nonterminal  differentiation state  by  >90%, 
Table I. Comparison of  Mitogenic Responsiveness of 3T3T and 
CSV3-1 Cells at the Predifferentiation Growth Arrest and 
Nonterminal Differentiation States 
3T3T cells  CSV3- l cells 
Mitogens  PGA  NTD  PGA  NTD 
FBS, 30%  +  +  +  + 
FBS, 10%  +  -  +  + 
Insulin, 1 p~g/ml  -  -  +  + 
Vanadate, 5 p,M  -  -  +  ND 
Cells at the predifferentiation growth arrest (PGA) or nonterminal differentiation 
(NTD) states were treated with either 30% FBS, 10% FBS, 1 Ixg/ml insulin, or 5 ixM 
vanadate for 24-48 h and mitogenic responsiveness was assayed by [3H]thymidine  in- 
corporation.  +, responsive to the mitogen; -, not responsive to the mitogen. 
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tivity of 3T3T and CSV3-1 cells during the process of adipocyte 
differentiation.  Nuclear extracts were prepared from growing, 
predifferentiation growth-arrested, and differentiated 3T3T and 
CSV3-1 cells, and electrophoretic mobility shift assays were per- 
formed using 10 ~g of nuclear protein and 0.035 pmol of 32p-end 
labeled oligonucleotides  containing  a  single AP-1  binding  site. 
Positions  of the specifically bound  DNA-protein complex and 
the freely migrating probes are indicated. Control lane represents 
the binding reaction mixture without  nuclear extracts.  Four ex- 
periments were performed that showed  consistent  results.  RG, 
rapidly growing; PGA, predifferentiation growth-arrested;  NTD, 
nonterminally differentiated. 
compared to that at the growing state. In contrast, adipo- 
cyte differentiation induced AP-1 DNA binding activity in 
CSV3-1 cells. As shown in Fig. 1, an ~l.5-fold and an ~2-fold 
increase in AP-1 binding activity is observed in prediffer- 
entiation growth-arrested and differentiated CSV3-1 cells, 
respectively. 
The differences in AP-1 DNA binding activity observed 
during adipocyte differentiation in 3T3T and CSV3-1 cells 
are specific since other transcription factors, such as AP-2 
and  Spl,  showed no difference between nontransformed 
and transformed cells (Fig. 2). Fig. 2 A  specifically shows 
that during the differentiation process, AP-2 DNA binding 
activity decreased in both 3T3T and CSV3-1 cells, indicat- 
ing that the increased AP-1 DNA binding activity in growth 
arrested and differentiated CSV3-1 cells is distinct. On the 
other  hand,  Spl  DNA binding activity slightly increased 
during differentiation in both cell types (Fig. 2 B), indicating 
that the decreased AP-1 DNA binding activity in growth- 
arrested and differentiated 3T3T cells is again unique. The 
AP-1 DNA binding specificity was also demonstrated by 
Figure 2.  Comparison of the changes  in AP-2 (A) and Spl (B) 
DNA binding activity between 3T3T and CSV3-1 ceils during the 
process  of adipocyte differentiation.  Nuclear extracts  were pre- 
pared from growing, predifferentiation growth-arrested,  and dif- 
ferentiated 3T3T and CSV3-1 cells, and electrophoretic mobility 
shift assays were performed using 10 p~g of nuclear protein and 
0.035 pmol of 32p-end labeled oligonucleotides  containing  either 
a single AP-2 binding site or a single Spl binding site. The posi- 
tion of freely migrating probes is indicated.  Control lane repre- 
sents the binding reaction mixture without nuclear extracts. RG, 
rapidly growing; PGA, predifferentiation growth-arrested;  NTD, 
nonterminalty differentiated. 
competition experiments using unlabeled oligonucleotides 
containing either an AP-1 binding site, or a mutated AP-1 
binding site, or an AP-3 binding site (data not shown). 
Therefore, there is a good correlation between prolifer- 
ative potential and AP-1 DNA binding activity. That is, re- 
pression of the  AP-1  DNA binding activity is associated 
with  the  progressive  reduction  in  growth  factor respon- 
siveness that occurs during 3T3T cell differentiation: Con- 
versely, increased AP-1 DNA binding activity in differen- 
tiated CSV3-1 cells is associated with retention of proliferative 
potential and even an increased mitogenic responsiveness. 
Characterization of  AP-1 Complexes in 
CSV3-1 and 3T3T Cells during the Process of 
Adipocyte Differentiation 
Since  AP-1  complexes are  composed of the  products  of 
the jun  and los gene  families,  we  next  investigated  the 
compositional changes of the AP-1 complexes that occur 
in CSV3-1  and 3T3T cells at the various stages of adipo- 
cyte differentiation. These studies were done by perform- 
ing  gel  supershift  assays using  specific antibodies.  Since 
Jun proteins are more critical than Fos proteins in deter- 
mining dimerization and DNA binding (Angel and Karin, 
1991)  and  since our previous studies  have demonstrated 
that c-Jun and JunB are more important than c-Fos in con- 
trolling 3T3T and CSV3-1 cell proliferation (Wang et al., 
1991; Wang and Scott, 1994), our experiments have focused 
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results of these studies are presented in Figs. 3 and 4. 
Fig. 3 demonstrates that the AP-1 complexes present in 
growing  CSV3-1  cells  are  predominantly  Jun-Fos  het- 
erodimers because the AP-1 DNA binding activity can be 
essentially completely supershifted by an anti-pan-Fos an- 
tibody  that  recognizes  all  Fos  proteins.  However,  as 
CSV3-1 cells undergo adipocyte differentiation, the AP-1 
complexes that  cannot be  supershifted  by the  anti-pan- 
Fos antibody are increased somewhat. The nature of those 
AP-1 complexes remains to be determined. Furthermore, 
Fig.  3  shows  that  in  CSV3-1  cells the Jun  proteins  that 
compose the AP-1 complexes are in a  defined ratio. The 
AP-1 DNA binding activity attributed to JunB, JunD, and 
c-Jun in growing CSV3-1 cells is 46, 21, and 8% of the total 
AP-1 DNA binding activity, respectively. As CSV3-1 cells 
undergo  predifferentiation growth  arrest  and  adipocyte 
differentiation, the increase in AP-1 DNA binding activity 
is  accounted for by a  significant increase in  JunD/AP-1 
DNA binding activity while the AP-1 DNA binding activ- 
ity attributed to JunB  and  c-Jun remains  essentially un- 
changed. As a result, the ratio of c-Jun and JunB to the to- 
tal AP-1 DNA binding activity decreases because of the 
increase in JunD. 
Fig. 4 presents the results of gel supershift assays using 
nuclear extracts prepared from growing, predifferentiation 
growth  arrested  and  nonterminally  differentiated  3T3T 
cells. Again,  at the growing state,  the AP-1  composition 
shows  no  significant  difference  than  that  of  growing 
CSV3-1  cells.  However, at  the predifferentiation growth 
arrest and nonterminal differentiation states in 3T3T cells, 
AP-1  DNA  binding  activity is  markedly  decreased  and 
within the residual AP-1 complexes c-Jun and JunB are es- 
sentially undetectable. JunD levels are also decreased dur- 
ing  differentiation, but  still  JunD  represents  the  major 
constituent  of the  residual  AP-1  DNA  binding  activity. 
Therefore, the  decrease  in  AP-1  DNA  binding  activity 
that occurs during the process of 3T3T cell differentiation 
results from a  decrease in all three Jun/AP-1  complexes, 
but primarily by a decrease in JunB and c-Jun. 
Fig. 5 quantitates and summarizes the data presented in 
Figs. 3 and 4. The changes in AP-1 DNA binding activity 
attributed to individual Jun proteins during the process of 
adipocyte differentiation of 3T3T and  CSV3-1  cells  are 
quantitatively illustrated using the total AP-1 DNA binding 
activity at  the growing state  as  a  reference. Specifically, 
Fig.  5  shows  that  adipocyte differentiation differentially 
modulates Jun/AP-1  DNA binding activities in 3T3T and 
CSV3-1  cells.  In  3T3T cells  (Fig.  5  A),  the  marked  de- 
crease in AP-1  DNA binding activity during differentia- 
tion is attributed to a decrease in all three Jun/AP-1 com- 
plexes, especially c-Jun/AP-1 and JunB/AP-1. In contrast, 
in CSV3-1 cells (Fig. 5 B), the increase in AP-1 DNA bind- 
ing activity during differentiation is primarily contributed 
by an increase in JunD/AP-1 while c-Jun/AP-1 and JunB/ 
AP-1  DNA  binding  activity  remains  essentially  un- 
changed. These data demonstrate that in both 3T3T and 
CSV3-1 cells, JunD/AP-1 binding activity is highest in qui- 
escent and differentiated states. 
To determine whether the changes in AP-1 DNA bind- 
ing activity attributed to individual Jun proteins that occur 
during  3T3T  and  CSV3-1  cell  differentiation  correlate 
Figure 3.  Analysis of the changes 
in  AP-1  composition  during 
CSV3-1 cell differentiation.  Nu- 
clear  extracts  were  prepared 
from growing, predifferentiation 
growth-arrested,  and  differenti- 
ated  CSV3-1 cells. Gel  super- 
shift assays were  performed by 
initially incubating 10 I-~g of nu- 
clear protein with 0.035 pmol of 
32p-end labeled  oligonucleotides 
containing a single AP-1 binding 
site for 20 min at room tempera- 
ture. Various  antibodies  (1  Ixg) 
against  either  c-Jun,  JunB, 
JunD, or all Fos proteins  (anti- 
pan-Fos) were then added to the 
binding  reaction  mixtures  and 
the reaction was allowed to pro- 
ceed for an additional 30 min at 
room  temperature.  The  posi- 
tions of supershifted  AP-1 com- 
ponents,  the  total  AP-1  DNA 
binding  activity, and freely mi- 
grating  probes  are  indicated. 
Four  experiments  were  per- 
formed that showed  similar re- 
sults.  RG,  rapidly  growing; 
PGA,  predifferentiation growth 
arrested;  NTD,  nonterminally 
differentiated. 
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AP-1 composition during 3T3T cell dif- 
ferentiation. Nuclear extracts were pre- 
pared from growing, predifferentiation 
growth-arrested, and differentiated 3T3T 
cells. Gel supershift  assays were per- 
formed by initially incubating 10 vLg of 
nuclear protein with 0.035 pmol of 32p_ 
end  labeled  oligonucleotides  contain- 
ing a  single AP-1  binding  site for 20 
min at room temperature. Various an- 
tibodies  (1  I~g) against  either  c-Jun, 
JunB, JunD, or all Fos proteins (anti- 
pan-Fos) were then added to the bind- 
ing reaction mixtures and the reaction 
was allowed to proceed for additional 
30 min at room temperature. The posi- 
tions  of  supershifted  AP-1  compo- 
nents, the total AP-1 DNA binding ac- 
tivity and freely migrating probes are 
indicated.  Two experiments were per- 
formed that showed similar results. RG, 
rapidly growing; PGA, predifferentia- 
tion growth-arrested; NTD, nontermi- 
nally differentiated. 
with the changes in the level of expression of c-Jun, JunB, 
and JunD, Western blot analysis was performed using nu- 
clear proteins comparable to those prepared for antibody 
supershift  assays.  The  results  of  these  studies  are  pre- 
sented in Fig. 6 A. Generally, the AP-1 DNA binding activ- 
ity changes associated with 3T3T and CSV3-1 cell differen- 
tiation (Figs. 3 and 4) are reflected by the changes in Jun 
protein expression levels (Fig. 6, B and C). However, sev- 
eral exceptions exist. For example, compared with grow- 
ing state, the c-Jun protein level remains relatively high at 
the predifferentiation growth arrest state in 3T3T cells but 
the AP-1 DNA binding activity attributed to c-Jun is un- 
detectable. In addition, the JunD protein level is actually 
increased at the predifferentiation growth arrest state even 
though the AP-1 DNA binding activity attributed to JunD 
remains low. Furthermore, in CSV3-1 cells, the JunB pro- 
tein level is decreased during the differentiation process, 
but the AP-1 DNA binding activity attributed to JunB re- 
mains  essentially  unchanged.  These  exceptions  suggest 
that functional regulation in Jun proteins, such as modula- 
tion in their phosphorylation status (Grover-Bardwick et 
al., 1994), also occurs during the process of adipocyte dif- 
ferentiation in addition to regulation at the expression level 
to regulate AP-1 DNA binding activities. 
Effects of Inhibiting Jun Protein Expression  on 
Cell Proliferation 
The results presented above suggest that cell proliferative 
potential is modulated by the changes in the balance of 
different Jun/AP-1 DNA binding activities in our cell sys- 
tem. Experiments therefore were carried out to determine 
if inhibition of the expression of individual Jun proteins by 
antisense oligodeoxyribonucleotides could affect cell pro- 
liferation. These studies were performed by using phos- 
phothionate-modified antisense and sense oligomers since 
it has been demonstrated that with this modification the 
oligomers remain stable  in  cells for up to 24 h  (Brenn- 
scheidt et al., 1994). For these studies, differentiating cells 
at the predifferentiation growth arrest state were used. 
We first tested the prediction that decreasing JunD lev- 
els in differentiating CSV3-1 cells should allow c-Jun and 
JunB to act as the dominant activating AP-1 factors and 
thereby  to  promote  cell  proliferation.  We  specifically 
treated  predifferentiation  growth-arrested  CSV3-1  cells 
with antisense oligomers to junD for 6 to 24 h  while the 
cells were maintained in differentiation-inducing medium. 
Cell proliferation was then assayed by [3H]thymidine in- 
corporation. Fig. 7 A shows that antisense junD oligomers 
induce a  highly significant mitogenic responsiveness in a 
dosage-dependent manner  in  quiescent  CSV3-1  cells in 
the absence of any other added growth factors. More spe- 
cifically, antisense junD oligomers at a concentration of 5 
~g/ml  induce  an  ~10%  maximum  mitogenic  response 
(maximum is defined as the mitogenic response when cells 
are  stimulated  with  10%  FBS  which  typically  induces 
>90% of the cells to grow). An ~60% maximum mitoge- 
nic response is achieved at a concentration of 40 p,g/ml and 
higher dosages show no increased mitogenic effects. Fig. 7 B 
further demonstrates that treatment of quiescent CSV3-1 
cells with antisense junD oligomers for 24 h downregulates 
JunD protein level significantly. At the concentration of 
40 p,g/ml, a >80% downregulation at JunD protein level is 
achieved.  Sense  oligomers  at  the  same  concentrations 
show only minimal inhibitory effect (<20%) on JunD pro- 
tein expression. 
To reproduceably detect repression of JunD expression 
by JunD antisense treatment of cells requires analysis of 
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Figure 5.  Comparison of the relative changes in Jun/AP-1 DNA 
binding activity between 3T3T (A) and CSV3-1(B) cells  during 
the process of adipocyte differentiation. Data presented in Figs. 3 
and 4 were quantitated by densitometric analysis and the relative 
changes in AP-1 DNA binding activity attributed to c-Jun, JunB, 
or JunD determined by supershift assays are reported as the per- 
centages relative to the total AP-1 DNA binding activity of grow- 
ing 3T3T or CSV3-1 cells which is represented by the first lanes 
of Figs.  3 and 4. RG, rapidly growing; PGA, predifferentiation 
growth-arrested;  NTD,  nonterminally  differentiated.  --~3---, c- 
Jun/AP-1; ---A---,  JunB/AP-  1; -<>-, JunD/AP-1. 
cells treated for different time intervals between 12 to 24 h, 
because of the apparent variable concentration of nucleases 
in various lots of human plasma and serum. 
Since  differentiating  3T3T  cells  contain  essentially  no 
c-Jun/AP-1  and  JunB/AP-1  DNA  binding  activities,  we 
predicted  that  decreasing JunD/AP-1  should have no ef- 
fect on these cells. To test this, antisense junD oligomers 
were added to differentiating 3T3T cells as above and no 
mitogenic effect could be detected (data not shown). Fur- 
thermore, sense junD, antisense and sense c-jun, and anti- 
Figure 6.  Western blot anal- 
ysis of the Jun protein levels 
in the nuclear extracts com- 
parable to those used for gel 
supershift  assays.  (A)  10 ~g 
of nuclear  protein  prepared 
from growing, predifferentia- 
tion growth-arrested, and dif- 
ferentiated 3T3T and CSV3-1 
cells  was  subjected  to  elec- 
trophoresis  on  10%  SDS- 
polyacrylamide  gels  and 
Western  blotting,  c-Jun, 
JunB, and JunD were identi- 
fied by probing the nitrocel- 
lulose  membranes  with  spe- 
cific  antibodies  used  for gel 
supershifl assays. Two exper- 
iments were  performed  that 
showed  similar  results.  The 
changes  in  Jun  protein  ex- 
pression  levels  during  3T3T 
(B) and CSV3-1  (C) cell dif- 
ferentiation were quantitated 
by densitometric analysis and 
are reported  as the percent- 
ages relative to those of rap- 
idly growing cells  where the 
c-Jun, JunB, and JunD protein 
levels  are  defined  as  100%. 
RG,  rapidly  growing; PGA, 
predifferentiation  growth- 
arrested;  NTD,  nontermi- 
nally differentiated.  ---~--, c- 
Jun; ---A---,  JunB; --O---,  JunD. 
sense  and sense junB oligomers were not mitogenic in ei- 
ther quiescent differentiating CSV3-1 or 3T3T cells (data not 
shown). 
We next examined the effects of antisense c-jun, junB, 
and junD  oligomers on  the  induction  of DNA  synthesis 
when predifferentiation  growth-arrested cells were stimu- 
lated with 10% FBS. These experiments  were specifically 
performed to determine which of the Juns are required for 
the induction of DNA synthesis. Differentiating prediffer- 
entiation growth-arrested cells were pretreated with oligo- 
mers for 2  h  and then exposed to 10%  FBS for an addi- 
tional 24 to 30 h  in the  presence  of the  oligomers.  DNA 
synthesis was assayed by [3H]thymidine incorporation. 
Fig. 8 A  shows that antisense oligomers to c-jun at a con- 
centration of 5 I~g/ml significantly blocked the FBS-induced 
DNA synthesis in predifferentiation growth-arrested CSV3-1 
cells (:,-10% inhibition). At the concentration of 40 p,g/ml, 
~75%  inhibition  was  observed.  Higher  concentrations 
showed no increased inhibitory effect.  Sense c-jun oligo- 
mers at the same concentrations however showed no sig- 
nificant inhibitory effects. Fig. 8 B  further shows that anti- 
sense c-jun oligomers inhibited FBS-induced c-Jun expression, 
whereas sense oligomers did not. When quiescent CSV3-1 
cells were similarly treated with antisense junB oligomers, 
similar  results  were obtained.  Fig. 9 A  specifically shows 
that  at  a  concentration  of 5  ixg/ml,  antisense junB oligo- 
mers  inhibited  FBS-induced  DNA  synthesis  by  ,-~20%. 
The  maximum inhibition  was achieved  at  the  concentra- 
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the induction of DNA synthesis in CSV3-1 cells and the effects of 
antisense and sense junD oligomers on the expression of JunD. 
(A)  Predifferentiation growth-arrested CSV3-1  cells were  ex- 
posed to  antisense junD oligomers at the  indicated concentra- 
tions for 24 to 30 h without the addition of serum or any other 
growth factors. DNA synthesis was assayed by [3H]thymidine in- 
corporation and is reported as the percentage of maximum mito- 
genic response where 100% maximum is defined as the mitogenic 
effect of 10%  FBS. Data  are expressed as the mean  _+  SD of 
three  separate  experiments  (each  in  triplicate)  minus  back- 
ground.  (B)  Predifferentiation  growth-arrested  CSV3-1  ceils 
were treated with antisense (AS) or sense (S) junD oligomers at 
the indicated concentrations for 6 to 24 h. In each experiment the 
optimum treatment time to observe the effect of JunD antisense 
had to be determined due to the apparent different stability of 
the oligonucleotide in various lots of human plasma and serum. 
100  txg of cellular protein was subjected to electrophoresis on 
10%  SDS-polyacrylamide gel and Western blot analysis. JunD 
(N40 kD) is identified by probing with a specific  antibody described 
in Materials and Methods. 
tion of 40 ~g/ml which blocked DNA synthesis by ~80%. 
Sense  oligomers showed  no significant inhibitory effects. 
Again, Fig. 9  B  demonstrates  that  antisense junB oligo- 
mers  inhibited  FBS-induced  JunB  expression,  whereas 
sense oligomers showed no significant effects. In addition, 
antisense (but not sense) c-jun and junB oligomers showed 
similar inhibitory effects on FBS-induced DNA  synthesis 
in predifferentiation growth-arrested 3T3T cells (data not 
shown). In contrast, neither antisense nor sense junD oli- 
gomers inhibited FBS-induced DNA synthesis in differen- 
tiating CSV3-1 and 3T3T ceils (data not shown). 
Discussion 
Regulation of the AP-1 transcription factors has been pro- 
posed to be critically important in the control of cell prolif- 
eration and neoplastic transformation  (Angel and Karin, 
Figure 8.  Effects of antisense and sense c-jun oligodeoxyribonu- 
cleotides on the induction of DNA synthesis and on the induction 
of c-Jun  expression by  serum.  (A)  Predifferentiation growth- 
arrested CSV3-1  cells were pretreated with antisense or sense 
c-jun oligomers at the indicated concentrations for 2 h followed 
by exposure to 10% FBS for an additional 24 to 30 h in the pres- 
ence of the oligomers. DNA synthesis was measured by [3H]thy- 
midine incorporation and is reported as the percentage of inhibi- 
tion where zero percent inhibition represents the mitogenic effect 
of 10% FBS in the absence of antisense or sense oligomers. Data 
are expressed as the mean -+ SD of three separate experiments 
(each  in  triplicate)  minus  background.  (B)  Predifferentiation 
growth-arrested CSV3-1 cells were treated with antisense (AS) or 
sense (S) c-jun oligomers as described above at the indicated con- 
centrations. 100 I~g of cellular protein was subjected to electro- 
phoresis on 10% SDS-polyacrylamide  gel and Western blot anal- 
ysis. c-Jun  (~40  kD)  is  identified by probing with  a  specific 
antibody described in Materials and Methods. [~, antisense; [], 
sense. 
1991).  Numerous  studies  have  demonstrated  that  c-jun 
and junB  function  as  immediate  early growth  factor re- 
sponse genes and activation of these two genes (especially 
c-jun) is required for cell cycle progression (Ryder et al., 
1988; Ryder and Nathans, 1988; Ryseck et al., 1988; Hersch- 
man, 1991).  It was also reported that cells overexpressing 
c-jun  showed  a  decreased  serum  requirement  for  their 
growth  (Castellazzi et al., 1991).  In Friend erythroleuke- 
mia cells, inhibition of c-jun expression by antisense RNA 
or  oligomers  caused  reversible  proliferative  arrest  and 
withdrawal  from  the  cell cycle  (Smith  and  Prochownik, 
1992) and promoted dimethyl sulfoxide-induced erythroid 
differentiation (Francastel et al., 1994). Overexpression of 
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cleotides on the induction  of DNA synthesis and on the induction 
of JunB  expression  by serum.  (A)  Predifferentiation  growth- 
arrested CSV3-1 cells were pretreated with  antisense  or sense 
junB oligomers at the indicated  concentrations for 2 h followed 
by exposure to 10% FBS for an additional  24 to 30 h in the pres- 
ence of the oligomers. DNA synthesis was measured by [3H]thy- 
midine incorporation and is reported as the percentage of inhibi- 
tion where zero percent inhibition represents the mitogenic effect 
of 10% FBS in the absence of antisense  or sense oligomers. Data 
are expressed as the mean -+ SD of three separate experiments 
(each  in  triplicate)  minus  background.  (B)  Predifferentiation 
growth-arrested CSV3-1 cells were treated with antisense (AS) or 
sense (S) junB oligomers as described  above at the indicated con- 
centrations.  100 lxg of cellular  protein was subjected  to electro- 
phoresis on 10% SDS-polyacrylamide gel and Western blot anal- 
ysis. JunB  (~40  kD)  is  identified  by probing with  a  specific 
antibody described  in Materials  and Methods.  [], antisense;  [], 
sense. 
c-jun  in  these  cells, on the  other hand,  resulted  in  a  de- 
creased ability to undergo differentiation (Francastel et al., 
1994). The mitogenic response to tumor necrosis factor--or 
in human fibroblasts also requires c-Jun since these cells 
fail to proliferate if cultured in the presence of antisense 
c-jun  oligodeoxyribonucleotides  (Brach  et  al.,  1993).  In 
addition, the AP-1 DNA binding activity is decreased sub- 
stantially  during  the  aging  process  of human  fibroblasts 
(Riabowol  et  al.,  1992)  and  selective inhibition  of AP-1 
DNA activity with retinoids effectively inhibits the prolif- 
eration of several tumor cell lines (Fanjul et al., 1994). In 
murine  3T3T cells,  the  decreased  growth  factor respon- 
siveness is specifically associated with a decreased serum in- 
ducibility of c-]un and junB (Wang and Scott, 1994). 
Numerous viral oncogenes and carcinogenic agents have 
been shown to activate AP-1 DNA binding activity. Exam- 
pies include v-src, v-mos, polyoma middle T antigen, Ha-ras, 
neu,  v-raf,  v-yes,  v-fps,  dimethylbenzanthracene,  4-nitro- 
quinolineoxide,  ionizing  radiation,  ultraviolet  light,  and 
asbestos  (Sherman  et  al.,  1990;  Angel  and  Karin,  1991; 
Heintz et al., 1993; Suzuki et al., 1994). Among these, ion- 
izing radiation and asbestos were reported to specifically 
induce  c-jun  expression  (Sherman et al.,  1990;  Heintz et 
al., 1993).  In fact, overexpression of c-]un alone will lead to 
cell transformation (Castellazzi et al.,  1991; Hughes et al., 
1992; Watts et al.,  1995).  Further  evidence indicates  that 
the transformation induced by c-jun overexpression is suf- 
ficiently mediated by Jun homodimers since heterodimer- 
ization with Fos proteins is not  required  (Hughes et al., 
1992). In JB6 mouse epidermal cells, progressive elevation 
of AP-1 DNA binding activity, which was primarily attrib- 
uted to an increase in c-jun expression, was demonstrated 
during the process of preneoplastic-to-neoplastic progres- 
sion (Dong et al., 1995b). Inhibition of AP-1 DNA binding 
activity by AP-1 inhibitors such as retinoic acid, fluocino- 
lone acetonide, or forskolin, or by transfection of a domi- 
nant negative c-jun mutant encoding a transcriptionally in- 
active product reversed the transformation phenotype or 
blocked transformation induced  by tumor promoter 12- 
O-tetradecanoylphorbol-13-acetate or EGF (Dong et al., 
1994,  1995a; Li et al.,  1996).  Using spontaneously revert- 
ing  cell  lines,  it  was  also  found  that  c-jun  was  overex- 
pressed in highly tumorigenic clones and the reversion to a 
nontumorigenic  phenotype  resulted  in  a  dramatic  de- 
crease in c-jun  expression (Lavrovsky et al., 1994).  Com- 
pared with c-jun, junB appears to be less potent in trans- 
forming cells (Castellazzi et al., 1991). However, elevated 
expression ofjunB seems essential for v-fos-induced trans- 
formation of Rat-1 cells (Van Amsterdam et al., 1994). 
Unlike c-]un and junB, junD is usually constitutively ex- 
pressed and is not inducible by growth factors (Hirai et al., 
1989; Ryder et al., 1989).  Overexpression ofjunD does not 
promote cell proliferation nor transformation (Castellazzi 
et  al.,  1991).  Therefore, JunD  appears to have  different 
functions  than c-Jun and JunB  in regulating cell growth. 
Recently, it was reported that overexpression of junD ac- 
tually slowed cell growth, which resulted in an increase in 
the percentage of cells in G0/G1 phase of the cell cycle, and 
partially  antagonized  ras-induced  transformation  (Pfarr 
et al., 1994).  Thus, JunD may have a function opposed to 
c-Jun  and  JunB  in  regulating  cell  proliferation,  that  is, 
JunD promotes quiescence. Pfarr et al. (1994), in fact, cor- 
related high JunD and low c-Jun levels with growth arrest 
and low JunD  and high c-Jun levels with proliferation. A 
high ratio of c-Jun to JunD also correlated with the sever- 
ity of the transformed phenotype (Pfarr et al.,  1994).  Simi- 
lar  changes  have  also  been  observed in  papillomavirus- 
transformed mouse cell lines in which an increase in the 
c-Jun and JunB to JunD ratio became evident as cells pro- 
gressed from fibromatosis to fibrosarcoma (Bossy-Wetzel 
et al., 1992).  Therefore, Jun/AP-1 transcription factors can 
be  dissected  into  two  parts:  c-Jun/AP-1  and  JunB/AP-1 
positively regulate cell growth, and JunD/AP-1 negatively 
regulates cell growth. It has however not been determined 
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and negative Jun/AP-1 transcription factors modulate cel- 
lular proliferative potential. 
To investigate if adipocyte differentiation modulates the 
balance of positive and negative Jun/AP-1 to regulate pro- 
liferative potential, we have used the well-characterized 
3T3T and CSV3-1  cell systems. We demonstrate that in 
SV-40  T  antigen-transformed  CSV3-1  cells,  total  AP-1 
DNA binding activity increases 1.5- to 2-fold at the predif- 
ferentiation growth arrest and nonterminal differentiation 
states, respectively. This increase is primarily attributed to 
an increase in the expression of JunD/AP-1.  The c-Jun/ 
AP-1 and JunB/AP-1 binding activities in contrast remain 
constant and relatively high in cells at these states. In con- 
trast,  in  nontransformed  3T3T  cells,  total  AP-1  DNA 
binding activity decreases progressively during the differ- 
entiation process. The residual AP-1 DNA binding activity 
that exists in differentiated cells is primarily contributed 
by JunD even though JunD/AP-1 DNA binding activity is 
also repressed markedly in these cells. The c-Jun/AP-1 and 
JunB/AP-1 levels are essentially undetectable in differen- 
tiated 3T3T cells since their expression is transcriptionally 
repressed (Wang and Scott, 1994). 
These observations support the hypothesis that the rea- 
son CSV3-1 cells do not lose their growth factor respon- 
siveness even though they are fully differentiated is  be- 
cause they retain relatively high levels of c-Jun/AP-1 and 
JunB/AP-1. Furthermore, the hypothesis suggests that the 
fact that these cells have a JunD/AP-1 DNA binding activ- 
ity higher than c-Jun/AP-1 and JunB/AP-1 DNA binding 
activities explains why they can growth arrest and differ- 
entiate.  On  the  other hand,  3T3T cells show a  reduced 
growth factor responsiveness once they are differentiated 
because their c-Jun/AP-1  and JunB/AP-1  DNA  binding 
activities are so low and because of that they require much 
less JunD/AP-1 to antagonize c-Jun and JunB to maintain 
a differentiated state. This hypothesis predicted that mito- 
genesis should result in quiescent CSV3-1 cells if the level 
of JunD/AP-1 was reduced so that c-Jun/AP-1 and JunB/ 
AP-1 could function maximally to promote proliferation. 
The results indeed show that treatment of differentiating 
CSV3-1  cells  with  antisense junD  oligomers  effectively 
promote mitogenesis, which is not observed in differenti- 
ating 3T3T cells. This is so because in CSV3-1 cells, repres- 
sion of JunD expression changes the balance between c-Jun 
and JunB versus JunD. Since c-Jun/AP-1 and JunB/AP-1 
are  already present in  CSV3-1  cells at  a  relatively high 
level, they do not need to be further induced to drive cells 
into the cell cycle. In 3T3T cells, however, repression of 
JunD expression itself is not sufficient to enhance cell pro- 
liferation because c-Jun/AP-1  and JunB/AP-1  levels are 
too low and would have to be induced for proliferation to 
occur. This hypothesis is further supported by findings that 
antisense c-jun and antisense junB oligomers both effec- 
tively block serum-induced DNA synthesis in CSV3-1 and 
3T3T cells, indicating that both c-Jun and JunB are indeed 
functioning as positive regulators for proliferation in our 
cell systems. These data together strongly suggest that the 
balance between positive and negative Jun/AP-1 transcrip- 
tion factors is critical to regulating a cell's proliferative po- 
tential during differentiation. To the best of our knowl- 
edge,  this  is  the  first  report  showing  that  differential 
modulation of the ratio of c-Jun/AP-1 and JunB/AP-1 to 
JunD/AP-1 by a biological process such as differentiation 
in transformed and nontransformed cells can determine 
whether cells retain or lose their growth factor responsive- 
ness. 
The results presented here raise a  series of interesting 
questions for future studies. The first question concerns 
why adipocyte differentiation selectively represses c-jun 
and junB inducibility by serum in nontransformed 3T3T 
cells but not in transformed CSV3-1 cells. Since c-jun and 
jun8  repression in  3T3T adipocytes occurs at  the  tran- 
scription level (Wang and Scott, 1994) and since differenti- 
ation does not induce significant changes in the expression 
of growth factor receptors and associated signaling path- 
ways  (Wang,  H.,  Z.  Xie,  and  R.E.  Scott, manuscript in 
preparation),  we  hypothesize  that  differentiation  may 
preferentially activate specific negative regulators for c-jun 
and junB transcription in nontransformed cells and that 
transformation blocks this effect of differentiation. In this 
regard,  it  is  important  to  emphasize  that  the  data  pre- 
sented in this paper do not show a significant difference in 
the ratio of c-Jun/AP-1 and JunB/AP-1 to JunD/AP-1 be- 
tween growing undifferentiated transformed CSV3-1 and 
nontransformed 3T3T cells, even though data from other 
cell systems have shown some differences (Bossy-Wetzel 
et al., 1992; Pfarr et al., 1994). One explanation is that SV- 
40  T  antigen-induced  transformation  does  not  require 
AP-1  participation (Wasylyk et al.,  1988).  On the  other 
hand, transformation induced by agents such as ras or pap- 
illomavirus (Bossy-Wetzel et al.,  1992; Pfarr et al., 1994) 
may use an AP-1--dependent pathway (Angel and Karin, 
1991; Suzuki et al., 1994). Therefore, the changing balance 
between positive and negative Jun/AP-1 DNA binding ac- 
tivities observed in differentiating CSV3-1 cells are proba- 
bly the result of a combination of effects of cellular trans- 
formation and  differentiation rather than being directly 
caused by the expression of SV-40 T antigen in those cells. 
In fact, it has been demonstrated that T antigen expression 
is transcriptionally repressed once CSV3-1 cells differenti- 
ate into adipocytes (Estervig et al., 1989; Scott et al., 1989). 
Future studies will use other DNA tumor virus transform- 
ing proteins, such as adenovirus E1A or human papilloma- 
virus E7, that have similar functions as SV-40 large T antigen, 
to  investigate  whether adipocyte differentiation induces 
similar compositional changes  in Jun/AP-1  transcription 
factors in E1A- or E7-transformed cells as in CSV3-1 cells. 
The  second  question  concerns  the  molecular  mecha- 
nisms  by which junD is overexpressed in differentiating 
CSV3-1  cells.  It is  not  clear  at  present whether the  in- 
creased JunD protein level that leads to increased JunD/ 
AP-1 DNA binding activity is due to an increased tran- 
scription rate,  stabilization  of the  mRNA,  an  increased 
translation  rate,  or  a  decreased JunD  degradation.  Al- 
though  the  junD  mRNA  level  shows  no  significant 
changes  after short-term serum stimulation in quiescent 
NIH 3T3 ceils (Hirai et al., 1989), the possibility that grow- 
ing and differentiated CSV3-1 cells may show a difference 
at junD mRNA level deserves further investigation. It has 
been reported that  the  rate  of incorporation of labeled 
amino acids into JunD protein in quiescent cells is much 
lower than in growing cells (Pfarr et al., 1994), suggesting 
that an increased protein stability may be also involved. 
The Journal of Cell Biology, Volume 134, 1996  1160 The  third  question  concerns  the  interrelationship  be- 
tween  c-Jun, JunB,  and JunD  AP-1  DNA  activities.  At 
growth-arrested and differentiated  states, elevated JunD/ 
AP-1  binding activity can function to prevent cells from 
entering  the  cell  cycle.  However,  the exact  mechanisms 
concerning how JunD/AP-1 functions in this regard is not 
known. Since all AP-1 complexes in quiescent and differ- 
entiated CSV3-1  and 3T3T cells  are predominantly Fos- 
Jun heterodimers,  the possibility that JunD may dimer- 
ize with c-Jun or JunB to suppress their functions is low. 
Other possibilities include that JunD-Fos might compete 
with  c-Jun-Fos  or  JunB-Fos  for  DNA  binding  or  that 
JunD-Fos may regulate genes that are primarily involved 
in negatively controlling cell proliferation, whereas c-Jun- 
Fos and JunB-Fos may regulate genes that facilitate pro- 
liferation.  How  c-Jun  and JunB  cooperate  in  positively 
controlling cell proliferation is also an important question. 
Although JunB is more  abundant than c-Jun in CSV3-1 
cells, the antisense data show that both are equally impor- 
tant for cell growth, suggesting that c-Jun and JunB may 
regulate different sets of growth-related genes. 
The fourth question concerns the possibility that in dif- 
ferentiating CSV3-1 cells the AP-1 complexes may recruit 
new protein(s)  which modulates  the  AP-1  activity.  This 
possibility is supported by observations that a small por- 
tion of the  AP-1  complexes  presented  in differentiating 
CSV3-1 cells cannot be supershifted by antibodies against 
either  pan-Fos or three Jun proteins, whereas  the AP-1 
complexes  in  growing  CSV3-1  cells  can  be  supershifted 
completely by anti-pan-Fos antibodies. Understanding the 
nature of this portion of the AP-1 complexes may help to 
explain further the molecular mechanisms by which differ- 
entiating CSV3-1 cells show an increased growth factor re- 
sponsiveness. The possibility that adipocyte differentiation 
may modulate the phosphorylation status of Jun proteins 
is also worth further investigation since the DNA binding 
affinity and the transactivation activity of AP-1 can be al- 
tered significantly by changes in Jun protein phosphoryla- 
tion (Boyle et al., 1991). 
The final question that needs to be studied is whether 
adipocyte  differentiation  differentially  regulates  the  ex- 
pression and activity of various Fos proteins in 3T3T and 
CSV3-1 cells. Although our previous studies have demon- 
strated that the differentiation process does not affect c-fos 
expression in 3T3T cells  (Wang and Scott, 1994), the ex- 
pression and/or function of other fos genes, such as fosB, 
fra-1, and fra-2, may be affected. The possibility exists that 
different  Fos  proteins  may  preferentially  dimerize  with 
different Jun proteins at different biological states. These 
possible changes in Fos proteins during differentiation, to- 
gether with the changes in Jun proteins, which lead to dif- 
ferent combinations of Fos-Jun in differentiated cells, may be 
more effective in influencing a cell's proliferative potential. 
In summary, the current studies have clearly established 
that differentiation can modulate a cell's proliferative po- 
tential by changing the balance of positive  and negative 
Jun/AP-1 in different ways in nontransformed and trans- 
formed cells. 
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